BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20493730)

  • 1. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
    Nurieva RI; Zheng S; Jin W; Chung Y; Zhang Y; Martinez GJ; Reynolds JM; Wang SL; Lin X; Sun SC; Lozano G; Dong C
    Immunity; 2010 May; 32(5):670-80. PubMed ID: 20493730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.
    Kriegel MA; Rathinam C; Flavell RA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.
    Mukai A; Iijima H; Hiyama S; Fujii H; Shinzaki S; Inoue T; Shiraishi E; Kawai S; Araki M; Hayashi Y; Kondo J; Mizushima T; Kanto T; Egawa S; Nishida T; Tsujii M; Takehara T
    J Gastroenterol; 2014 Dec; 49(12):1524-35. PubMed ID: 24356810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.
    Seroogy CM; Soares L; Ranheim EA; Su L; Holness C; Bloom D; Fathman CG
    J Immunol; 2004 Jul; 173(1):79-85. PubMed ID: 15210761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
    Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
    J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype.
    MacKenzie DA; Schartner J; Lin J; Timmel A; Jennens-Clough M; Fathman CG; Seroogy CM
    J Biol Chem; 2007 Mar; 282(13):9696-9702. PubMed ID: 17259178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells.
    Anandasabapathy N; Ford GS; Bloom D; Holness C; Paragas V; Seroogy C; Skrenta H; Hollenhorst M; Fathman CG; Soares L
    Immunity; 2003 Apr; 18(4):535-47. PubMed ID: 12705856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Notch signalling has ability to alter the proximal and distal TCR signalling events in human CD3
    Dar AA; Bhat SA; Gogoi D; Gokhale A; Chiplunkar SV
    Mol Immunol; 2017 Dec; 92():116-124. PubMed ID: 29078088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes.
    Su L; Lineberry N; Huh Y; Soares L; Fathman CG
    J Immunol; 2006 Dec; 177(11):7559-66. PubMed ID: 17114425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of Grail promotes CD8
    Haymaker C; Yang Y; Wang J; Zou Q; Sahoo A; Alekseev A; Singh D; Ritthipichai K; Hailemichael Y; Hoang ON; Qin H; Schluns KS; Wang T; Overwijk WW; Sun SC; Bernatchez C; Kwak LW; Neelapu SS; Nurieva R
    Nat Commun; 2017 Aug; 8(1):239. PubMed ID: 28798332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
    Nguyen TTT; Wang ZE; Shen L; Schroeder A; Eckalbar W; Weiss A
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33974042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response.
    Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2008 Feb; 7(4):284-90. PubMed ID: 18295731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
    Su LL; Iwai H; Lin JT; Fathman CG
    J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR stimulation without co-stimulatory signals induces expression of "tolerogenic" genes in memory CD4 T cells but does not compromise cell proliferation.
    Xie A; Zheng X; Khattar M; Schroder P; Stepkowski S; Xia J; Chen W
    Mol Immunol; 2015 Feb; 63(2):406-11. PubMed ID: 25306961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex.
    Park Y; Jin HS; Lopez J; Lee J; Liao L; Elly C; Liu YC
    Nat Immunol; 2016 Mar; 17(3):286-96. PubMed ID: 26829767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy.
    Lineberry NB; Su LL; Lin JT; Coffey GP; Seroogy CM; Fathman CG
    J Immunol; 2008 Aug; 181(3):1622-6. PubMed ID: 18641297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
    Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
    J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the E3 ubiquitin ligase gene related to anergy in lymphocytes in glucose and lipid metabolism in the liver.
    Nakamichi S; Senga Y; Inoue H; Emi A; Matsuki Y; Watanabe E; Hiramatsu R; Ogawa W; Kasuga M
    J Mol Endocrinol; 2009 Feb; 42(2):161-9. PubMed ID: 19060180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.